Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24405491http://www.w3.org/2000/01/rdf-schema#comment"

Background and aim

Heterozygous inactivating mutations in the glucokinase (GCK) gene cause a hyperglycemic condition termed maturity-onset diabetes of the young (MODY) 2 or GCK-MODY. This is characterized by mild, stable, usually asymptomatic, fasting hyperglycemia that rarely requires pharmacological intervention. The aim of the present study was to screen for GCK gene mutations in Asian Indian subjects with mild hyperglycemia.

Subjects and methods

Of the 1,517 children and adolescents of the population-based ORANGE study in Chennai, India, 49 were found to have hyperglycemia. These children along with the six patients referred to our center with mild hyperglycemia were screened for MODY 2 mutations. The GCK gene was bidirectionally sequenced using BigDye(®) Terminator v3.1 (Applied Biosystems, Foster City, CA) chemistry. In silico predictions of the pathogenicity were carried out using the online tools SIFT, Polyphen-2, and I-Mutant 2.0 software programs.

Results

Direct sequencing of the GCK gene in the patients referred to our Centre revealed one novel mutation, Thr206Ala (c.616A>G), in exon 6 and one previously described mutation, Met251Thr (c.752T>C), in exon 7. In silico analysis predicted the novel mutation to be pathogenic. The highly conserved nature and critical location of the residue Thr206 along with the clinical course suggests that the Thr206Ala is a MODY 2 mutation. However, we did not find any MODY 2 mutations in the 49 children selected from the population-based study. Hence prevalence of GCK mutations in Chennai is <1:1,517.

Conclusions

This is the first study of MODY 2 mutations from India and confirms the importance of considering GCK gene mutation screening in patients with mild early-onset hyperglycemia who are negative for β-cell antibodies."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.org/dc/terms/identifier"doi:10.1089/dia.2013.0244"xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Chowdhury S."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Balamurugan K."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Goswami S."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Mohan V."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Radha V."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Jahnavi S."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Kanthimathi S."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Ranjani H."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/author"Sonya J."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/name"Diabetes Technol Ther"xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/pages"180-185"xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/title"Glucokinase gene mutations (MODY 2) in Asian Indians."xsd:string
http://purl.uniprot.org/citations/24405491http://purl.uniprot.org/core/volume"16"xsd:string
http://purl.uniprot.org/citations/24405491http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24405491
http://purl.uniprot.org/citations/24405491http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24405491
http://purl.uniprot.org/uniprot/#_A7LFL1-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
http://purl.uniprot.org/uniprot/#_L0HBA3-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
http://purl.uniprot.org/uniprot/#_M4PPE1-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
http://purl.uniprot.org/uniprot/#_M4PPE6-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
http://purl.uniprot.org/uniprot/#_M4PPI4-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
http://purl.uniprot.org/uniprot/#_M4PPI9-mappedCitation-24405491http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24405491
▶